Skip to main content


Figure 4 | Stem Cell Research & Therapy

Figure 4

From: A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

Figure 4

Changes in daily insulin requirements over time. This figure shows the insulin requirements of T2DM patients at pre-operation and 1, 3, 6 and 12 months post-transplantation. The results are shown as the mean ± S.D. *P <0.05 compared with pretreatment. The analysis included 17 patients that received exogenous insulin at months 0, 1, 3, 6 and 12. T2DM, Type 2 diabetes mellitus.

Back to article page